ARID1A and ovarian cancer: Although ARID1A alterations occur in ~30–50% of ovarian clear cell carcinomas, ovarian clear cell cancers are a rare subset of ovarian cancer, and only one patient was designated with this pathologic entity in the dataset; hence, the frequency of ARID1A mutations in this histology was not evaluable [13].